This inventor holds 1 USPTO granted patent and 2 published patent applications. Top assignee: Sawai Pharmaceutical Co., Ltd.. Active years: 2017.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2017
Title: Yasushi Fukuhara: Innovator in Pharmaceutical Preparations
Introduction
Yasushi Fukuhara is a notable inventor based in Osaka, Japan. He has made significant contributions to the field of pharmaceuticals, particularly with his innovative work on candesartan cilexetil-containing preparations. His expertise and dedication to research have led to the development of a unique formulation that enhances the efficacy of this medication.
Latest Patents
Fukuhara holds a patent for a candesartan cilexetil-containing preparation. This preparation includes candesartan cilexetil and lauromacrogol, with the latter being present at a ratio of 2.4 parts by weight or less concerning 100 parts by weight of the preparation. Additionally, the formulation may contain various pharmacologically acceptable additives, such as a diluent, a disintegrant, and a binder, which contribute to its effectiveness.
Career Highlights
Throughout his career, Yasushi Fukuhara has been associated with Sawai Pharmaceutical Co., Ltd., where he has played a crucial role in advancing pharmaceutical research and development. His work has not only contributed to the company's portfolio but has also had a positive impact on patient care through improved medication formulations.
Collaborations
Fukuhara has collaborated with several talented individuals in his field, including Tomoya Nakagawa and Kenji Uetsuki. These partnerships have fostered a collaborative environment that encourages innovation and the sharing of ideas, ultimately leading to advancements in pharmaceutical science.
Conclusion
Yasushi Fukuhara's contributions to the pharmaceutical industry, particularly through his patent on candesartan cilexetil-containing preparations, highlight his role as an innovator. His work continues to influence the development of effective medications that benefit patients worldwide.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
